vimarsana.com

Page 62 - தேசிய ஆரோக்கியம் காப்பீடு திட்டம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Kidney Disease: Late detection, high cost hinder treatment for affected Nigerians

Kidney Disease: Late detection, high cost hinder treatment for affected Nigerians The cost of each kidney dialysis session is N23,000 at the Garki hospital. 5 min read After undergoing dialysis on Thursday at the Garki general hospital in Abuja, Dannuma Tadi, a retired army officer, said he was already thinking of where to get money for the next one. The cost of each dialysis session is N23,000 at the hospital and Mr Tadi needs at least two treatments each week to keep his system filtered and running. Mr Tadi, 64, has been battling high blood pressure and diabetes for nearly 30 years. Two years ago, he was diagnosed with end-stage (stage 5) kidney disease.

Put mental health medications under NHIS — Women With Mental Health appeal to gov t

Some women with mental health conditions in the country have appealed to government to, as a matter of urgency, initiate interventions to improve mental health service provision in the country, including absorbing Mental Health Medications into the National Health Insurance Scheme (NHIS).

Glaucoma blinds 60,000

Graphic Online BY: Doreen Andoh Category: General News Mr Harrison Kofi Abutiate (2nd right), National President, Glaucoma Patients Association of Ghana, and Dr Dzifa Bella Ofori-Adjei (right), Secretary, Opthalmological Society of Ghana, speaking to the media after the launch. Picture: EBOW HANSON 30.5k Shares 705 The Ophthalmological Society of Ghana (OSG) says the asymptomatic nature of glaucoma makes everybody vulnerable to the disease, which is a major cause of irreversible blindness. As it joined the Glaucoma Patients Association of Ghana and the Ministry of Health to launch the World Glaucoma Week in Accra yesterday, the society asked members of the public to go for eye screening at least once every year to save their sight.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.